Epidemiology of rare cancers and inequalities in oncologic outcomes
Fabio Pannozzo, Isabelle Baldi(Pancreatic Cancer Action Network), Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Guido Mazzoleni, Patrick Arveux, Alice Nennecke, Jón G. Jónasson(Reykjavík University), Daniela Pierannunzio(Istituto Superiore di Sanità), Roberta De Angelis(Istituto Superiore di Sanità), Mario Šekerija(London Cancer), Marc Maynadié(Universidad de Granada), G. Schubert-Fritschle(Ludwig-Maximilians-Universität München), Pascale Grosclaude(Seoul National University Children's Hospital), Silvia Rossi(University of Naples Federico II), Florence Molinié, Bernd Holleczek(Krebsregister Saarland), Diego Serraino(Centro di Riferimento Oncologico), Santa Santaquilani, Brigitte Trétarre(Pancreatic Cancer Action Network), K. Henau, Anne‐Sophie Woronoff, Alain Monnereau, Michel Robaszkiewicz(Universidad de Granada), Arnold Knijn(Istituto Superiore di Sanità), Sandra Mallone(Istituto Superiore di Sanità), Maarit K. Leinonen(University of Helsinki), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Xavier Troussard(Centre Hospitalier Universitaire de Caen Normandie), Nea Malila(Istituto Superiore di Sanità), Harry Comber(Universidad de Granada), Andrea Tavilla
HAL (Le Centre pour la Communication Scientifique Directe)
September 1, 2017
Cited by 0
Related Papers
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
|European Journal of Cancer|2015|486